Variant report

Variant	nsv1024657
Chromosome Location	chr6:167526198-167555488
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:971)
CpG islands
(count:1283)
Chromatin interactive
region (count:26)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:971 , 50 per page) page: 1 2 3 4 5 6 7 ... 20

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr6:167536241-167537214	HepG2	liver:	n/a	n/a
2	ARID3A	chr6:167554236-167555094	HepG2	liver:	n/a	n/a
3	ARID3A	chr6:167544586-167544925	HepG2	liver:	n/a	n/a
4	ATF1	chr6:167538302-167538600	K562	blood:	n/a	n/a
5	ATF2	chr6:167531955-167532665	GM12878	blood:	n/a	n/a
6	ATF2	chr6:167526348-167528528	GM12878	blood:	n/a	chr6:167528159-167528170
7	ATF2	chr6:167543402-167543914	GM12878	blood:	n/a	n/a
8	ATF2	chr6:167526259-167528702	GM12878	blood:	n/a	chr6:167528159-167528170
9	BATF	chr6:167528075-167528382	GM12878	blood:	n/a	chr6:167528158-167528171
10	BATF	chr6:167531467-167531964	GM12878	blood:	n/a	n/a
11	BATF	chr6:167548004-167548270	GM12878	blood:	n/a	n/a
12	BATF	chr6:167526513-167526858	GM12878	blood:	n/a	n/a
13	BATF	chr6:167527974-167528395	GM12878	blood:	n/a	chr6:167528158-167528171
14	BATF	chr6:167527373-167527794	GM12878	blood:	n/a	chr6:167527701-167527714
15	BATF	chr6:167544573-167544836	GM12878	blood:	n/a	chr6:167544714-167544724 chr6:167544713-167544724
16	BATF	chr6:167544528-167544880	GM12878	blood:	n/a	chr6:167544714-167544724 chr6:167544713-167544724
17	BCL11A	chr6:167526456-167526921	GM12878	blood:	n/a	n/a
18	BCL11A	chr6:167527356-167527873	GM12878	blood:	n/a	n/a
19	BCL11A	chr6:167526571-167526902	GM12878	blood:	n/a	n/a
20	BCL11A	chr6:167544561-167544756	GM12878	blood:	n/a	n/a
21	BCL11A	chr6:167528003-167528368	GM12878	blood:	n/a	n/a
22	BCL3	chr6:167526432-167526868	GM12878	blood:	n/a	n/a
23	BCL3	chr6:167527404-167527793	GM12878	blood:	n/a	n/a
24	BCL3	chr6:167533727-167534142	GM12878	blood:	n/a	n/a
25	BCLAF1	chr6:167527246-167528315	GM12878	blood:	n/a	n/a
26	BCLAF1	chr6:167526319-167527196	GM12878	blood:	n/a	n/a
27	BCLAF1	chr6:167527291-167528256	GM12878	blood:	n/a	n/a
28	BCLAF1	chr6:167535685-167536283	GM12878	blood:	n/a	n/a
29	BCLAF1	chr6:167526257-167527008	GM12878	blood:	n/a	n/a
30	BHLHE40	chr6:167526382-167528843	GM12878	blood:	n/a	chr6:167527798-167527807 chr6:167527798-167527807 chr6:167527792-167527813 chr6:167527799-167527808
31	BHLHE40	chr6:167543426-167545128	GM12878	blood:	n/a	n/a
32	BHLHE40	chr6:167535456-167536226	GM12878	blood:	n/a	n/a
33	BHLHE40	chr6:167544472-167545230	HepG2	liver:	n/a	n/a
34	BHLHE40	chr6:167554100-167554428	GM12878	blood:	n/a	n/a
35	BHLHE40	chr6:167533703-167534351	GM12878	blood:	n/a	n/a
36	BHLHE40	chr6:167544417-167545088	HepG2	liver:	n/a	n/a
37	BRCA1	chr6:167527615-167528325	GM12878	blood:	n/a	n/a
38	BRCA1	chr6:167532565-167532656	GM12878	blood:	n/a	n/a
39	CBX3	chr6:167533506-167533907	K562	blood:	n/a	n/a
40	CBX3	chr6:167533508-167533952	K562	blood:	n/a	n/a
41	CEBPB	chr6:167536334-167536627	HepG2	liver:	n/a	n/a
42	CEBPB	chr6:167536251-167536723	HepG2	liver:	n/a	n/a
43	CEBPB	chr6:167544631-167544765	HepG2	liver:	n/a	n/a
44	CEBPB	chr6:167544526-167544794	HepG2	liver:	n/a	n/a
45	CEBPB	chr6:167536399-167536537	K562	blood:	n/a	n/a
46	CEBPB	chr6:167554643-167555056	HepG2	liver:	n/a	n/a
47	CEBPB	chr6:167526313-167528466	GM12878	blood:	n/a	n/a
48	CEBPB	chr6:167544564-167544889	HepG2	liver:	n/a	n/a
49	CEBPB	chr6:167536275-167536700	HepG2	liver:	n/a	n/a
50	CEBPB	chr6:167536195-167536648	HepG2	liver:	n/a	n/a

(count:1283 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:167530185-167530235	NHDF-neo	bronchial:	n/a
2	chr6:167536056-167536106	AG09319	gingival:	n/a
3	chr6:167530185-167530235	NHDF-neo	bronchial:	n/a
4	chr6:167536056-167536106	AG09319	gingival:	n/a
5	chr6:167530253-167530303	IMR90	lung:	fetal
6	chr6:167536069-167536119	U87	brain:	n/a
7	chr6:167530343-167530393	HEEpiC	esophagus:	n/a
8	chr6:167536184-167536234	PFSK-1	brain:	n/a
9	chr6:167529765-167529815	Hela-S3	cervix:	n/a
10	chr6:167536069-167536119	AG04450	lung:	fetal
11	chr6:167550145-167550195	SK-N-MC	brain:	n/a
12	chr6:167544901-167544951	Hela-S3	cervix:	n/a
13	chr6:167544901-167544951	HAEpiC	amniotic membrane:	n/a
14	chr6:167536184-167536234	MCF-7	breast:	n/a
15	chr6:167550145-167550195	GM19239	blood:	n/a
16	chr6:167529765-167529815	HRPEpiC	eye:	n/a
17	chr6:167536056-167536106	A549	lung:	n/a
18	chr6:167536521-167536571	AG10803	skin:	n/a
19	chr6:167536521-167536571	HAEpiC	amniotic membrane:	n/a
20	chr6:167536056-167536106	HepG2	liver:	n/a
21	chr6:167536069-167536119	PANC-1	pancreas:	n/a
22	chr6:167536056-167536106	MCF-7	breast:	n/a
23	chr6:167536086-167536136	NT2-D1	testis:	n/a
24	chr6:167536063-167536113	LNCaP	prostate:	n/a
25	chr6:167536069-167536119	SK-N-SH	brain:	n/a
26	chr6:167554790-167554840	HRE	kidney:	n/a
27	chr6:167544964-167545014	NB4	blood:	n/a
28	chr6:167530253-167530303	ECC-1	luminal epithelium:	n/a
29	chr6:167529678-167529728	AG04449	skin:	fetal
30	chr6:167536521-167536571	AG04449	skin:	fetal
31	chr6:167535909-167535959	HIPEpiC	eye:	n/a
32	chr6:167535171-167535221	PrEC	prostate:	n/a
33	chr6:167554790-167554840	BE2_C	brain:	n/a
34	chr6:167536069-167536119	HAEpiC	amniotic membrane:	n/a
35	chr6:167536056-167536106	HL-60	blood:	n/a
36	chr6:167536184-167536234	PANC-1	pancreas:	n/a
37	chr6:167529765-167529815	HEK293	kidney:	embryo
38	chr6:167529678-167529728	AoSMC	blood vessel:	n/a
39	chr6:167550205-167550255	HCPEpiC	choroid plexus:	n/a
40	chr6:167536521-167536571	T-47D	breast:	n/a
41	chr6:167535909-167535959	GM12891	blood:	n/a
42	chr6:167535909-167535959	HMEC	breast:	n/a
43	chr6:167554790-167554840	HNPCEpiC	eye:	n/a
44	chr6:167554790-167554840	PFSK-1	brain:	n/a
45	chr6:167544964-167545014	SKMC	muscle:	n/a
46	chr6:167554790-167554840	PANC-1	pancreas:	n/a
47	chr6:167530253-167530303	GM12878	blood:	n/a
48	chr6:167535171-167535221	MCF-7	breast:	n/a
49	chr6:167529678-167529728	ECC-1	luminal epithelium:	n/a
50	chr6:167530343-167530393	K562	blood:	n/a

(count:26 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:167530415..167533348-chr6:167542772..167545436,2	K562	blood:
2	chr6:167533573..167534443-chr6:167549334..167550301,3	MCF-7	breast:
3	chr6:167200031..167200812-chr6:167555407..167555996,2	K562	blood:
4	chr6:167533318..167534107-chr6:167555281..167555885,2	MCF-7	breast:
5	chr6:167188755..167189454-chr6:167555413..167556221,2	MCF-7	breast:
6	chr6:167547071..167549495-chr6:167560421..167562886,2	K562	blood:
7	chr6:167188403..167189352-chr6:167555280..167555897,4	K562	blood:
8	chr6:167513997..167514603-chr6:167533661..167534449,3	MCF-7	breast:
9	chr6:167530846..167533349-chr6:167533846..167535491,2	K562	blood:
10	chr6:167533318..167534107-chr6:167555281..167555885,2	MCF-7	breast:
11	chr6:167199917..167200852-chr6:167555354..167555927,2	MCF-7	breast:
12	chr6:167514002..167514845-chr6:167533614..167534539,2	MCF-7	breast:
13	chr6:167411045..167411873-chr6:167555413..167555930,2	MCF-7	breast:
14	chr6:167533925..167534442-chr6:167554372..167555227,2	MCF-7	breast:
15	chr6:167410903..167412089-chr6:167555232..167556268,5	MCF-7	breast:
16	chr6:167543795..167547055-chr6:167549259..167552787,3	K562	blood:
17	chr6:167530846..167533349-chr6:167533846..167535491,2	K562	blood:
18	chr6:167533573..167534443-chr6:167549334..167550301,3	MCF-7	breast:
19	chr6:167459004..167459905-chr6:167555024..167555917,3	MCF-7	breast:
20	chr6:167536255..167537788-chr6:167539934..167541454,2	K562	blood:
21	chr6:167533925..167534442-chr6:167554372..167555227,2	MCF-7	breast:
22	chr6:167530415..167533348-chr6:167542772..167545436,2	K562	blood:
23	chr6:167550499..167553471-chr6:167563406..167565855,2	K562	blood:
24	chr6:167185783..167186302-chr6:167555369..167556350,2	K562	blood:
25	chr6:167543795..167547055-chr6:167549259..167552787,3	K562	blood:
26	chr6:167186547..167188661-chr6:167553295..167555799,2	K562	blood:

No data

Variant related genes	Relation type
TCP10L2	TF binding region
CCR6	TF binding region
TCP10L2	CpG island
CCR6	CpG island
ENSG00000112486	chromatin interactions
ENSG00000265828	chromatin interactions

Extended variants
information (count: 1239 )
Associated
traits (count: 83 )

Variant overlapped rSNPs/rCNVs (count:1239 , 50 per page) page: 1 2 3 4 5 6 7 ... 25

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs968333	chr6:167526198-167526199	Weak transcription Flanking Active TSS Active TSS Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs556047967	chr6:167526232-167526233	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
3	rs537383505	chr6:167526233-167526234	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs577370257	chr6:167526242-167526243	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs114093444	chr6:167526251-167526252	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs373822983	chr6:167526267-167526268	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs560126999	chr6:167526273-167526274	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs527362500	chr6:167526293-167526294	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
9	rs542384463	chr6:167526296-167526297	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
10	rs182569987	chr6:167526330-167526331	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
11	rs116701794	chr6:167526364-167526365	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
12	rs550452558	chr6:167526371-167526372	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
13	rs112122027	chr6:167526373-167526374	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS	n/a	n/a	Overlapped CNVs	n/a
14	rs112853039	chr6:167526466-167526467	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
15	rs114436484	chr6:167526467-167526468	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
16	rs532899434	chr6:167526484-167526485	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
17	rs547995803	chr6:167526502-167526503	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
18	rs1015077	chr6:167526506-167526507	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
19	rs113556095	chr6:167526525-167526526	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
20	rs548410530	chr6:167526575-167526576	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
21	rs199510967	chr6:167526777-167526778	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
22	rs569991896	chr6:167526779-167526780	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
23	rs149763727	chr6:167526783-167526784	Weak transcription Active TSS Flanking Active TSS Enhancers Transcr. at gene 5' and 3'	n/a	n/a	Overlapped CNVs	n/a
24	rs145106259	chr6:167526834-167526835	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
25	rs577505231	chr6:167526836-167526837	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
26	rs6930998	chr6:167526940-167526941	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
27	rs553906826	chr6:167526957-167526958	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
28	rs572166873	chr6:167526972-167526973	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
29	rs114380028	chr6:167526973-167526974	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
30	rs372201389	chr6:167527070-167527071	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
31	rs111392045	chr6:167527089-167527090	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
32	rs576253580	chr6:167527095-167527096	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
33	rs6909252	chr6:167527097-167527098	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
34	rs6931530	chr6:167527200-167527201	Weak transcription Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Active TSS Bivalent Enhancer	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
35	rs186846068	chr6:167527215-167527216	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs142772152	chr6:167527288-167527289	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs141147196	chr6:167527295-167527296	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs6908364	chr6:167527296-167527297	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs530240035	chr6:167527310-167527311	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs529916368	chr6:167527369-167527370	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs548615275	chr6:167527371-167527372	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs542563432	chr6:167527395-167527396	Weak transcription Flanking Active TSS Enhancers Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs144859590	chr6:167527457-167527458	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
44	rs79470115	chr6:167527499-167527500	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
45	rs552134929	chr6:167527532-167527533	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
46	rs376693297	chr6:167527544-167527545	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
47	rs538516154	chr6:167527545-167527546	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
48	rs189906056	chr6:167527564-167527565	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
49	rs572161809	chr6:167527579-167527580	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
50	rs528743528	chr6:167527595-167527596	Enhancers Weak transcription Flanking Active TSS Active TSS Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:83)

Disease	PMID	Source
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Biliary cancer	19435499	CNVD
Medulloblastoma	21979893	CNVD
Malaria	21533027	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Ewing''s sarcoma	17952124	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Neuroblastoma	18923191	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Melanoma	18172304	CNVD
Cancer	21637783	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Follicular lymphoma	19010834	CNVD
Non-small cell lung cancer	21044232	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Phyllodes tumor	17334353	CNVD
Breast cancer	16608533	CNVD
Non-small cell lung cancer	21385341	CNVD
Prostate cancer	16705090	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Colorectal cancer	16272173	CNVD
Ependymoma	16718352	CNVD
Gastric cancer	17908304	CNVD
High-proliferative meningiomas	17937814	CNVD
Intracranial tumor	16823260	CNVD
Monoclonal gammopathy of undetermined significance	17077331	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Breast cancer	16272173	CNVD
Wilms tumour	21544195	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Congenital diaphragmatic hernia	21085971	CNVD
Malignant melanoma	18718029	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Breast cancer	21858162	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Breast cancer	17603634	CNVD
Developmental delay	19490664	CNVD
Burkitt''s lymphoma	18698080	CNVD
Neurodevelopmental disorder	22521361	CNVD
small cell lung cancer	20016488	CNVD
Adenoid cystic carcinoma	18698036	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Leukemia	18688285	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Burkitt''s lymphoma	19759907	CNVD
Esophageal cancer	21851588	CNVD
T-cell acute lymphoblastic leukemia	18185524	CNVD
Breast cancer	17133270	CNVD
Testicular germ cell tumor	18059402	CNVD
Chordoma	18071362	CNVD
Glioblastoma multiforme	19435819	CNVD
Developmental delay	21147756	CNVD
Ovarian cancer	21720365	CNVD
abnormal development	18461090	CNVD
Epilepsy	22083797	CNVD
Myelofibrosis	22110671	CNVD
chordoma	19801981	CNVD
Myxofibrosarcoma	16751306	CNVD
Autism	17483303	CNVD
Acute lymphoblastic leukemia	21098271	CNVD
Acute myeloid leukemia	19651601	CNVD
Sudden cardiac death	19188705	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:564 , 50 per page) page: 1 2 3 4 5 6 7 ... 12

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:167503600-167527200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr6:167517600-167529800	Weak transcription	Spleen	Spleen
3	chr6:167519400-167527800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
4	chr6:167520400-167529800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
5	chr6:167524200-167526800	Weak transcription	Placenta Amnion	Placenta Amnion
6	chr6:167524400-167527400	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
7	chr6:167525000-167527600	Active TSS	Primary T cells effector/memory enriched fromperipheralblood	blood
8	chr6:167525000-167529000	Flanking Active TSS	Primary T helper memory cells from peripheral blood 2	blood
9	chr6:167525200-167528600	Flanking Active TSS	Primary B cells from peripheral blood	blood
10	chr6:167525400-167526200	Active TSS	Primary T cells fromperipheralblood	blood
11	chr6:167525400-167526200	Weak transcription	Primary T killer memory cells from peripheral blood	blood
12	chr6:167525400-167527400	Active TSS	Rectal Mucosa Donor 29	rectum
13	chr6:167525600-167526600	Active TSS	Primary T regulatory cells fromperipheralblood	blood
14	chr6:167525800-167526200	Active TSS	Primary T helper cells PMA-I stimulated	--
15	chr6:167525800-167526200	Active TSS	Primary T helper cells fromperipheralblood	blood
16	chr6:167525800-167526400	Flanking Active TSS	Primary B cells from cord blood	blood
17	chr6:167525800-167526400	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
18	chr6:167525800-167526600	Active TSS	Duodenum Mucosa	Duodenum
19	chr6:167525800-167528400	Flanking Active TSS	GM12878-XiMat	blood
20	chr6:167526000-167526400	Active TSS	Primary mononuclear cells fromperipheralblood	Blood
21	chr6:167526000-167527200	Transcr. at gene 5' and 3'	Primary T helper 17 cells PMA-I stimulated	--
22	chr6:167526000-167527600	Flanking Active TSS	Primary T helper memory cells from peripheral blood 1	blood
23	chr6:167526000-167531600	Weak transcription	Primary T helper naive cells from peripheral blood	blood
24	chr6:167526200-167526400	Flanking Active TSS	Primary T cells fromperipheralblood	blood
25	chr6:167526200-167526800	Enhancers	Primary hematopoietic stem cells short term culture	blood
26	chr6:167526200-167527000	Active TSS	Primary T killer memory cells from peripheral blood	blood
27	chr6:167526200-167527000	Active TSS	Rectal Smooth Muscle	rectum
28	chr6:167526200-167527400	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
29	chr6:167526200-167527600	Flanking Active TSS	Primary T helper cells fromperipheralblood	blood
30	chr6:167526400-167526600	Active TSS	Primary T cells fromperipheralblood	blood
31	chr6:167526400-167526600	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
32	chr6:167526400-167526800	Active TSS	Primary B cells from cord blood	blood
33	chr6:167526400-167526800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
34	chr6:167526400-167527000	Enhancers	Primary T cells from cord blood	blood
35	chr6:167526400-167527200	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
36	chr6:167526600-167527000	Flanking Active TSS	Duodenum Mucosa	Duodenum
37	chr6:167526600-167527200	Flanking Active TSS	Primary Natural Killer cells fromperipheralblood	blood
38	chr6:167526600-167527400	Enhancers	Primary hematopoietic stem cells	blood
39	chr6:167526600-167527600	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood
40	chr6:167526600-167528000	Enhancers	Fetal Stomach	stomach
41	chr6:167526600-167528800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
42	chr6:167526800-167527200	Bivalent Enhancer	Fetal Muscle Trunk	muscle
43	chr6:167526800-167527200	Bivalent Enhancer	Fetal Muscle Leg	muscle
44	chr6:167526800-167527600	Flanking Active TSS	Primary B cells from cord blood	blood
45	chr6:167526800-167529000	Enhancers	Placenta Amnion	Placenta Amnion
46	chr6:167526800-167532600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
47	chr6:167527000-167527200	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
48	chr6:167527000-167527800	Active TSS	Duodenum Mucosa	Duodenum
49	chr6:167527000-167529000	Weak transcription	Rectal Smooth Muscle	rectum
50	chr6:167527000-167532200	Weak transcription	Primary T cells from cord blood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links